HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy

NCT00393302 | Completed

• 1 other identifier: 03-326
• Study Type: observational
• Target: 1,074
• Locations: 1 country
• Sites: 1

Brief Summary

Mother-to-child transmission of HIV is an important but preventable mode of infection. Prevention depends on identifying pregnant women infected with HIV and offering medications during pregnancy which can dramatically decrease the chances of transmission. Currently universal screening of all pregnant women for HIV is recommended in the province of Ontario. Unfortunately the rates of screening are still low: estimates place the average rate at 50% -60%. We believe that rates in our clinic at the Women's Health Care Centre are significantly higher in part because all our patients have a first obstetrical visit. This is an unhurried visit with a trained obstetrical nurse who offers pre-test counselling and explores reasons why patients refuse testing. We hypothesize that with this system, acceptance rates for HIV screening are significantly higher than the provincial average.

Conditions

HIV; AIDS Virus; Pregnancy

Keywords

HIV testing in pregnant women

Study Arms (1)

1 & 2

1. Retrospective chart review: HIV testing rates 2. Prospective cohort group: HIV testing rates

Procedure: HIV screening in pregnancy

Interventions

HIV screening in pregnancy PROCEDURE

1 & 2

Eligibility Criteria

• Age: 16 Years - 45 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

All pregnant women attending antenatal intake appointments at the Women's Health Care Centre at St. Michael's Hospital in Toronto, Canada between September 2003 and February 2006.

You may qualify if:

• All pregnant women attending antenatal intake appointments at the Women's Health Care Centre at St. Michael's Hospital in Toronto, Canada between September 2003 and February 2005.

You may not qualify if:

• Any pregnant women obtaining antenatal care at other health care facilities.

Sponsors & Collaborators

• Unity Health Toronto: lead

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Related Publications (1)

• Yudin MH, Moravac C, Shah RR. Influence of an "opt-out" test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol. 2007 Jul;110(1):81-6. doi: 10.1097/01.AOG.0000267497.39041.06.

  PMID: 17601900 DERIVED

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

HIV Testing; Pregnancy

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Intervention Hierarchy (Ancestors)

Microbiological Techniques; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques; Reproduction; Reproductive Physiological Phenomena; Reproductive and Urinary Physiological Phenomena

Study Officials

• Mark H Yudin, MD MSc

  St. Michael's Hospital & the University of Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: October 26, 2006
• First Posted: October 27, 2006
• Study Start: September 1, 2003
• Primary Completion: January 1, 2006
• Study Completion: February 1, 2006
• Last Updated: February 22, 2019

Record last verified: 2019-02

Locations

CA (1)